The market just marked Acadia Healthcare Company down more than 16% in a single session, yet the headline from this quarter is not revenue collapse. The stock came into today already under pressure over the past week, and traders have seized on the company’s loss profile and trailing basic earnings per share of about US$12.44 in the red as the driving fear.

The emotional hit is about trust in the earnings path. Q2 net income of roughly US$10.9 million and basic earnings per share of about US$0.12 signal progress on the income statement, but the share price move shows that investors are still pricing Acadia Healthcare as if the trailing loss story is the only thing that matters.

Is Acadia Healthcare Company now trading at a genuine…